BAKER BROS. ADVISORS LP - Insider Non-Derivative Transactions at Neoleukin Therapeutics, Inc. (NLTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 5, 2023, BAKER BROS. ADVISORS LP's relationship to Neoleukin Therapeutics, Inc. (NLTX) is Director,TenPercentOwner, and currently has 1,658,190 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NLTX insiders.
Data Source: SEC.
BAKER BROS. ADVISORS LP - Insider Non-Derivative Transactions at NLTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 6, 2023 | X -- (Common Stock) | 57049 | 0 | 155874 |
| Oct 6, 2023 | X -- (Common Stock) | 535601 | 0 | 1658190 |